Can Ozempic Cause Pancreatitis?

Ozempic Risks - Thyroid Tumors: What Rat Studies Revealed and What We Still Don't Know

22 min · 7. apr. 2026
episode Ozempic Risks - Thyroid Tumors: What Rat Studies Revealed and What We Still Don't Know cover

Description

Ben Synth examines the thyroid tumor warning on Ozempic and GLP-1 medications, explaining why the FDA's black box label stems from rat studies showing C-cell tumors—a finding with uncertain human relevance. He explores the biological differences between rodent and human thyroid glands, who should absolutely avoid these drugs, and how to weigh this precautionary warning against proven metabolic benefits. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

Comments

0

Be the first to comment

Sign up now and become a member of the Can Ozempic Cause Pancreatitis? community!

Get Started

1 month for 9 kr.

Then 99 kr. / month · Cancel anytime.

  • Podcasts kun på Podimo
  • 20 lydbogstimer pr. måned
  • Gratis podcasts

All episodes

4 episodes

episode Can Ozempic Cause Pancreatitis? - Gallstones, Alcohol & Who Should Avoid GLP-1 Drugs artwork

Can Ozempic Cause Pancreatitis? - Gallstones, Alcohol & Who Should Avoid GLP-1 Drugs

Ben Synth explores often-overlooked Ozempic risks beyond pancreatitis and thyroid tumors, including gallstones, alcohol interactions, kidney disease, and smoking. He provides a practical nine-point checklist identifying who should exercise caution before starting semaglutide, emphasizing the critical need for thorough patient-doctor discussions about individual risk factors. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7. apr. 202624 min
episode Ozempic Risks - Thyroid Tumors: What Rat Studies Revealed and What We Still Don't Know artwork

Ozempic Risks - Thyroid Tumors: What Rat Studies Revealed and What We Still Don't Know

Ben Synth examines the thyroid tumor warning on Ozempic and GLP-1 medications, explaining why the FDA's black box label stems from rat studies showing C-cell tumors—a finding with uncertain human relevance. He explores the biological differences between rodent and human thyroid glands, who should absolutely avoid these drugs, and how to weigh this precautionary warning against proven metabolic benefits. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7. apr. 202622 min
episode Can Ozempic Cause Pancreatitis? - Parsing the Headlines from the Hard Data artwork

Can Ozempic Cause Pancreatitis? - Parsing the Headlines from the Hard Data

Ben Synth examines the conflicting evidence around Ozempic and pancreatitis risk—from alarming nine-fold increases in observational studies to neutral or protective signals in controlled trials. He explains why the data disagrees, who faces elevated risk, and what symptoms demand immediate medical attention when starting GLP-1 medications. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7. apr. 202624 min